373 related articles for article (PubMed ID: 36293446)
21. Mineralocorticoid Receptor (MR) trans-Activation of Inflammatory AP-1 Signaling: DEPENDENCE ON DNA SEQUENCE, MR CONFORMATION, AND AP-1 FAMILY MEMBER EXPRESSION.
Dougherty EJ; Elinoff JM; Ferreyra GA; Hou A; Cai R; Sun J; Blaine KP; Wang S; Danner RL
J Biol Chem; 2016 Nov; 291(45):23628-23644. PubMed ID: 27650495
[TBL] [Abstract][Full Text] [Related]
22. Aldosterone, mineralocorticoid receptors and vascular inflammation.
Funder JW
Mol Cell Endocrinol; 2004 Mar; 217(1-2):263-9. PubMed ID: 15134827
[TBL] [Abstract][Full Text] [Related]
23. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
Kawarazaki W; Fujita T
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
[TBL] [Abstract][Full Text] [Related]
24. Mineralocorticoid receptors in the metabolic syndrome.
Zennaro MC; Caprio M; Fève B
Trends Endocrinol Metab; 2009 Nov; 20(9):444-51. PubMed ID: 19800255
[TBL] [Abstract][Full Text] [Related]
25. EF domains are sufficient for nongenomic mineralocorticoid receptor actions.
Grossmann C; Freudinger R; Mildenberger S; Husse B; Gekle M
J Biol Chem; 2008 Mar; 283(11):7109-16. PubMed ID: 18184651
[TBL] [Abstract][Full Text] [Related]
26. Posttranslational Modifications of the Mineralocorticoid Receptor and Cardiovascular Aging.
Gadasheva Y; Nolze A; Grossmann C
Front Mol Biosci; 2021; 8():667990. PubMed ID: 34124152
[TBL] [Abstract][Full Text] [Related]
27. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor mutations.
Zennaro MC; Fernandes-Rosa F
J Endocrinol; 2017 Jul; 234(1):T93-T106. PubMed ID: 28348114
[TBL] [Abstract][Full Text] [Related]
28. Expression and function of the human mineralocorticoid receptor: lessons from transgenic mouse models.
Le Menuet D; Viengchareun S; Muffat-Joly M; Zennaro MC; Lombès M
Mol Cell Endocrinol; 2004 Mar; 217(1-2):127-36. PubMed ID: 15134811
[TBL] [Abstract][Full Text] [Related]
29. Nuclear shuttling precedes dimerization in mineralocorticoid receptor signaling.
Grossmann C; Ruhs S; Langenbruch L; Mildenberger S; Strätz N; Schumann K; Gekle M
Chem Biol; 2012 Jun; 19(6):742-51. PubMed ID: 22726688
[TBL] [Abstract][Full Text] [Related]
30. Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1.
Amazit L; Le Billan F; Kolkhof P; Lamribet K; Viengchareun S; Fay MR; Khan JA; Hillisch A; Lombès M; Rafestin-Oblin ME; Fagart J
J Biol Chem; 2015 Sep; 290(36):21876-89. PubMed ID: 26203193
[TBL] [Abstract][Full Text] [Related]
31. NF-YC functions as a corepressor of agonist-bound mineralocorticoid receptor.
Murai-Takeda A; Shibata H; Kurihara I; Kobayashi S; Yokota K; Suda N; Mitsuishi Y; Jo R; Kitagawa H; Kato S; Saruta T; Itoh H
J Biol Chem; 2010 Mar; 285(11):8084-93. PubMed ID: 20054001
[TBL] [Abstract][Full Text] [Related]
32. Cistrome of the aldosterone-activated mineralocorticoid receptor in human renal cells.
Le Billan F; Khan JA; Lamribet K; Viengchareun S; Bouligand J; Fagart J; Lombès M
FASEB J; 2015 Sep; 29(9):3977-89. PubMed ID: 26054365
[TBL] [Abstract][Full Text] [Related]
33. Evolution of the Mineralocorticoid Receptor.
Baker ME; Katsu Y
Vitam Horm; 2019; 109():17-36. PubMed ID: 30678855
[TBL] [Abstract][Full Text] [Related]
34. Molecular evolution of the switch for progesterone and spironolactone from mineralocorticoid receptor agonist to antagonist.
Fuller PJ; Yao YZ; Jin R; He S; Martín-Fernández B; Young MJ; Smith BJ
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18578-18583. PubMed ID: 31439819
[TBL] [Abstract][Full Text] [Related]
35. Vascular Consequences of Aldosterone Excess and Mineralocorticoid Receptor Antagonism.
Chrissobolis S
Curr Hypertens Rev; 2017; 13(1):46-56. PubMed ID: 28245785
[TBL] [Abstract][Full Text] [Related]
36. A critical region in the mineralocorticoid receptor for aldosterone binding and activation by cortisol: evidence for a common mechanism governing ligand binding specificity in steroid hormone receptors.
Rogerson FM; Yao YZ; Elsass RE; Dimopoulos N; Smith BJ; Fuller PJ
Mol Endocrinol; 2007 Apr; 21(4):817-28. PubMed ID: 17284665
[TBL] [Abstract][Full Text] [Related]
37. Aldosterone and the kidney.
Fourkiotis VG; Hanslik G; Hanusch F; Lepenies J; Quinkler M
Horm Metab Res; 2012 Mar; 44(3):194-201. PubMed ID: 22161301
[TBL] [Abstract][Full Text] [Related]
38. Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances.
Galuppo P; Bauersachs J
Eur J Clin Invest; 2012 Oct; 42(10):1112-20. PubMed ID: 22536780
[TBL] [Abstract][Full Text] [Related]
39. Modulation of transcriptional mineralocorticoid receptor activity by nitrosative stress.
Ruhs S; Strätz N; Schlör K; Meinel S; Mildenberger S; Rabe S; Gekle M; Grossmann C
Free Radic Biol Med; 2012 Sep; 53(5):1088-100. PubMed ID: 22749806
[TBL] [Abstract][Full Text] [Related]
40. Aldosterone, mineralocorticoid receptor, and heart failure.
Messaoudi S; Azibani F; Delcayre C; Jaisser F
Mol Cell Endocrinol; 2012 Mar; 350(2):266-72. PubMed ID: 21784127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
